Lung cancer – genetic predisposition - panel (NOD2, P16, P53 - 1 mutation, CYP1B1)
Analysis ID 215
Analysis location “GENESIS” Centre for Medical Genetics
Diagnosed illness Lung cancer – genetic predisposition - panel (NOD2, P16, P53 - 1 mutation, CYP1B1)
OMIM
Clinical information
Type of analysis Molecular
Type of biological material 5 ml of peripheral blood collected in an ETDA tube; DNA sample
Analyzed genes CYP1B1; TP53; CDKN2A (p16); NOD2 (3020insC)
Analysis description Analysis consists of a testing for the mutations in NOD2, P16, P53, and CYP1B1 genes, which increase the risk of developing lung cancer
Analysis indication Familial cases of lung cancer
Analysis time 1 - 2 weeks
Refund No
CGM laboratory name Laboratory for Molecular Genetics and Oncology